Beliz Bahar Karaoğlan, Medical Oncology Fellow at Ankara University, shared on X about recent paper by her as first author, titled “Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis” published on Springer Nature Link.
Authors: Beliz Bahar Karaoğlan, İremsu Öztürk, Cihangir Akyol, Berna Savaş, Güngör Utkan
“Is 3 months of adjuvant chemo enough for all low-risk stage III colon cancer patients? Our new study highlights the need for 6 months of chemo in patients with tumor deposits, specifically pT1-3N1c (without LN metastases).”